Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
This devastating neurodevelopmental disorder has no currently approved treatments.
Use of high-speed video microscopy and artificial intelligence provides calculated statistics like diastolic and systolic diameters, fractional shortening, and ejection fraction.
Indirect benefits could include how to lessen rejection of transplanted organs and damage to the transplanted tissue.
Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.
A newly identified subset of intestinal epithelial cells act as both the major target and a key responder in a mouse model of gut infection by the bacteria Citrobacter rodentium.
This serious mental health problem resists treatment, but a mouse model shows a potential new treatment.
Understanding the mechanisms underlying tolerance and hyperalgesia is essential to enhance morphine’s utility in chronic pain management.
Mortgage lending discrimination in the 1930s is still geographically associated with inequities in colon cancer care today. Colon cancer often can be treated successfully if detected early.
A modifier gene is one that changes the observable characteristics, called the phenotype, or molecular expression of other genes.